Survival curve for days from first challenge to acute viremia (first occurrence of VL equal to 1,000 copies per millilitre) for each treatment group. All pairwise comparisons were determined by two-tailed Wilcoxon testing, and significant differences ( P < 0.05, Bonferroni-corrected for multiple comparisons) are indicated for each mAb treatment (by legend colour) versus control.
